Lazard European Alpha Fund C AccRegister to Unlock Ratings |
Performance History | 31/10/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | 9.4 | 11.3 | -6.5 | 15.7 | 2.6 | |
+/-Cat | 0.1 | -4.1 | 2.3 | 2.1 | 0.1 | |
+/-B’mrk | 1.5 | -5.9 | 1.0 | 0.7 | -1.9 | |
Category: Europe ex-UK Equity | ||||||
Category Benchmark: Morningstar DM Eur xUK TME ... |
Key Stats | ||
NAV 22/11/2024 | GBP 12.59 | |
Day Change | 0.69% | |
Morningstar Category™ | Europe ex-UK Equity | |
IA (formerly IMA) Sector | Europe Excluding UK | |
ISIN | GB00B7WP6581 | |
Fund Size (Mil) 22/11/2024 | GBP 40.93 | |
Share Class Size (Mil) 22/11/2024 | GBP 4.66 | |
Max Initial Charge | - | |
Ongoing Charge 16/02/2024 | 0.77% |
Investment Objective: Lazard European Alpha Fund C Acc |
The objective of the Sub-Fund is to achieve capital growth, net of fees, in excess of the FTSE World Europe ex. UK Index, measured in sterling, over at least 5 years. The Sub-Fund will invest at least 80% in equities and equity-related securities (namely, shares, common and preferred stock, warrants and rights). The Sub-Fund will typically consist of between 45 to 60 holdings in European companies. The Sub-Fund is actively managed and may invest in companies in any industry sector and of any market capitalisation. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
Aaron Barnfather 03/03/2008 | ||
Paul Selvey-Clinton 31/03/2014 | ||
Click here to see others | ||
Inception Date 01/11/2012 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
FTSE World Eur Ex UK TR GBP | Morningstar DM Eur xUK TME NR EUR |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for Lazard European Alpha Fund C Acc | 30/09/2024 |
|
|
Top 5 Holdings | Sector | % |
Novo Nordisk AS Class B | Healthcare | 5.40 |
ASML Holding NV | Technology | 4.22 |
UniCredit SpA | Financial Services | 3.90 |
AXA SA | Financial Services | 3.13 |
SAP SE | Technology | 3.00 |
Increase Decrease New since last portfolio | ||
Lazard European Alpha Fund C Acc |